SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001104659-22-110519
Filing Date
2022-10-21
Accepted
2022-10-21 12:58:48
Documents
1
Group Members
BPIFRANCE S.A.CAISSE DES DEPOTS ET CONSIGNATIONSEPIC BPIFRANCE

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tm2228691d1_sc13da.htm SC 13D/A 110167
  Complete submission text file 0001104659-22-110519.txt   111882
Mailing Address 27-31 AVENUE DU GENERAL LECLERC MAISONS ALFORT, CEDEX I0 94710
Business Address 27-31 AVENUE DU GENERAL LECLERC MAISONS ALFORT, CEDEX I0 94710 33153898789
Bpifrance Participations SA (Filed by) CIK: 0001581835 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 117 AVENUE DE LUMINY BP 30191 MARSEILLE I0 13009
Business Address 117 AVENUE DE LUMINY BP 30191 MARSEILLE I0 13009 33430303030
Innate Pharma SA (Subject) CIK: 0001598599 (see all company filings)

IRS No.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-91173 | Film No.: 221322921
SIC: 2836 Biological Products, (No Diagnostic Substances)